Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis

Hepatology

Volumn 30, Issue 1, 1999, Pages 71-78

  Yamazaki, Klyoshl ^a,b,c   Suzuki, Kazuyuki ^c   Nakamura, Atsushi ^c   Sato, Shunichi ^c   Llndor, Keith D ^a   Batts, Kenneth P ^a   Tarara, James E ^b   Kephart, Gail M ^a   Kita, Hirohito ^a   Gleich, Gerald J ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR BASIC PROTEIN; URSODEOXYCHOLIC ACID;

ARTICLE; AUTOIMMUNE HEPATITIS; CELL INFILTRATION; DEGRANULATION; EOSINOPHIL; EOSINOPHILIA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; OBSTRUCTIVE JAUNDICE; PORTAL VEIN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; VIRUS HEPATITIS;

BLOOD PROTEINS; CELL DEGRANULATION; CHOLESTASIS; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; FEMALE; HEPATITIS, AUTOIMMUNE; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; PLACEBOS; PROTEINS; RADIOIMMUNOASSAY; RIBONUCLEASES; URSODEOXYCHOLIC ACID;

EID: 0033026044     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300121     Document Type: Article

References (26)

1. Gleich GJ, Kita H, Adolphson C. Eosinophils. In: Frank M, Austen K, Claman H, Unaue E, eds. Samter's Immunologic Diseases. Volume 1. Fifth ed. Boston: Little, Brown & Company, 1995;205-245.
2. Venge P, Dahl R, Fredens K, Peterson CGB. Epithelial injury by human eosinophils. Am Rev Respir Dis 1988;138:S54-S57.
3. Kaneko M, Kita H, Gleich GJ. Eosinophil basic proteins. In: Barnes PJ, Grunstein MM, Leff AR, Woolcook AJ, eds. Asthma. Philadelphia: Lippincott-Raven, 1997;593-607.
4. Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol 1979;123:2925-2927.
5. Kleine TJ, Gleich GJ, Lewis SA. Eosinophil major basic protein increases membrane permeability in mammalian urinary bladder epithelium. Am J Physiol 1998;275:C93-C103.
6. Venge P. Monitoring of asthma inflammation by serum measurements of eosinophil cationic protein (ECP). A new clinical approach to asthma management. Resp Med 1995;89:1-2.
7. Laurin JM, Lindor KD. Primary biliary cirrhosis. Dig Dis 1994;12:331-350.
8. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570-1580.
9. Van de Water J, Shimoda S, Niho Y, Coppel R, Ansari A, Gershwin ME. The role of T cells in primary biliary cirrhosis. Semin Liver Dis 1997;17:105-113.
10. Yamazaki K, Nakadate I, Suzuki K, Sato S, Masuda T. Eosinophilia in primary biliary cirrhosis. Am J Gastroenterol 1996;91:516-522.
11. Wirth HP, Heer P, Bertschinger P, Meyenberger C, Ammann R, Altorfer J. Flūchtige Eosinophilie bei primār biliārer Zirrhose. Schweiz Med Wochenschr 1993;123:2278-2283.
12. Kokubun M, Kuroda M, Takagi T, Saito K, Nishimaki T, Morito T, Kasukawa R. Eosinophilia in primary biliary cirrhosis. Nippon Shokakibyo Gakkai Zasshi 1990;87:1410-1416 (in Japanese).
13. Terasaki S, Nakanuma Y, Yamazaki M, Unoura M. Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study. HEPATOLOGY 1993;17:206-212.
14. Miyaguchi S, Oda M, Mori M, Imaeda H, Tsuzuki Y, Saito H, Kamegaya K, el al. Immunohistochemical characterization of hepatic eosinophil cationic protein in primary biliary cirrhosis. Int Hepatol Commun 1996;5:207-214.
15. Nakamura A, Yamazaki K, Suzuki K, Sato S. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis. Am J Gastroenterol 1997;92:2245-2249.
16. Miyaguchi S, Oda M, Tamano M, Matsubara K, Ishikawa Y, Kaneko H, Kamegaya Y, et al. Elevation of serum eosinophil cationic protein in primary biliary cirrhosis. Int Hepatol Commun 1994;2:285-288.
17. Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. HEPATOLOGY 1995;21:113-119.
18. Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM. Elevations in IFN-γ, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol 1996;80:311-320.
19. Gittlen SD, Schulman ES, Maddrey WC. Raised histamine concentrations in chronic cholestatic liver disease. Gut 1990;31:96-99.
20. Combes B. Ursodeoxycholic acid in primary biliary cirrhosis. Semin Liver Dis 1997;17:125-128.
21. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-890.
22. Bachrach WH, Hofmann AF. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part I. Dig Dis Sci 1982;27:737-761.
23. Dumont M, Erlinger S, Uchman S. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport. Gastroenterology 1980;79:82-89.
24. Heuman DM. Hepatoprotective properties of ursodeoxycholic acid. Gastroenterology 1993;104:1865-1870.
25. Neuberger J. Immune effects of ursodeoxycholic acid. In: Berg P, Lohse AW, Tiegs G, Wendel A, eds. Autoimmune Liver Disease. Dordrecht: Kluwer Academic Publishers, 1997;93-103.
26. Yoshikawa M, Tsujii T, Matsumura K, Yamao J, Matsumura Y, Kubo R, Fukui H, et al. Immunomodulatory effects of ursodeoxycholic acid on immune responses. HEPATOLOGY 1992;16:358-364.